Clinical trial
Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study…
NCT00177749 · University of Pittsburgh, Other · Terminated
Key facts
| NCT number | NCT00177749 |
|---|---|
| Title | Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095 |
| Official title | Open Label, Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095 |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Schering-Plough Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Fungal Infection |
| Intervention type | Drug |
| Interventions | Posaconazole |
| Enrollment | 10 |
| Start date | Aug 1, 2004 |
| Completion | Nov 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 17, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: